According to the FDA, the agency has received adverse reports after patients used compounded semaglutide, saying patients should not use a compounded drug if an approved drug is available to treat a patient
Clinical trials suggest the pill produces results on par with those of injections: Participants with obesity or overweight who took it for the full study period lost an average of about 17 percent of their body weight
doi: 10.3390/hemato3020024
The duration of semaglutide treatment is not one-size-fits-all
Bokman CL , Sfeir M, Chahwala V, Ginzburg E
Khi s dng ng hng dn, kt hp ch dinh dng cn i v bo v da khi nh nng, sn phm c th h tr ci thin sc t da, gip ln da sng khe v rng r hn theo thi gian